J&J Sees A Path Forward For Xarelto In Post-Hospital VTE Despite MARINER Failure
Executive Summary
The company says the MARINER data combined with prior MAGELLAN results in acute medically ill patients support prophylaxis for VTE following a hospital stay in select individuals. However, there is no regulatory path forward in heart failure based on the COMMANDER HF study.